ask="3.07"
ask_size="2900"
average_daily_volume="4203070"
bid="3.05"
bid_size="2000"
book_value="-1.75"
change="+0.06"
change_from_200_day_moving_average="-2.15"
change_from_50_day_moving_average="-1.44"
change_from_52_week_high="-5.97"
change_From_52_week_low="0.09"
change_in_percent="+2.01%"
close="3.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.37"
ebitda="-120.56M"
eps_estimate_current_year="-1.16"
eps_estimate_next_quarter="-0.03"
eps_estimate_next_year="-0.20"
ex_dividend_date="N/A"
float_shares="122562000"
high="3.15"
high_52_weeks="9.02"
last_trade_date="1/19/2017"
last_trade_price="3.05"
last_trade_size="508"
last_trade_time="4:00pm"
low="2.96"
low_52_weeks="2.96"
market_capitalization="395.33M"
moving_average_200_day="5.20"
moving_average_50_day="4.49"
name="Merrimack Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.00"
open="2.97"
pe_ratio="N/A"
peg_ratio="-0.50"
percent_change_from_200_day_moving_average="-41.31%"
percent_change_from_50_day_moving_average="-32.09%"
percent_change_from_52_week_high="-66.17%"
percent_change_from_52_week_low="+3.04%"
previous_close="2.99"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="3.71"
revenue="104.45M"
shares_outstanding="129615000"
short_ratio="14.12"
stock_exchange="NGM"
symbol="MACK"
volume="3623741"
weeks_range_52="2.96 - 9.02"
